Antimicrobial activity of ceftaroline against methicillin-resistant Staphylococcus aureus (MRSA) isolates collected in 2013–2014 at the Geneva University Hospitals

Antimicrobial Activity of Ceftaroline Tested againstStaphylococcus aureusfrom Surgical Skin and Skin Structure Infections in US Medical Centers

(2016) Helio S. Sader et al.   Surgical Infections

Whole-Genome Sequencing of Methicillin-Resistant Staphylococcus aureus Resistant to Fifth-Generation Cephalosporins Reveals Potential Non-mecA Mechanisms of Resistance

(2016) Alexander L. Greninger et al.   PLoS One

Mechanisms of Methicillin Resistance inStaphylococcus aureus

(2015) Sharon J. Peacock et al.   Annual Review of Biochemistry

In VitroActivity of Ceftaroline against Staphylococcus aureus Isolated in 2012 from Asia-Pacific Countries as Part of the AWARE Surveillance Program

(2015) Douglas J. Biedenbach et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Missense Mutations in PBP2A Affecting Ceftaroline Susceptibility Detected in Epidemic Hospital-Acquired Methicillin-Resistant Staphylococcus aureus Clonotypes ST228 and ST247 in Western Switzerland Archived since 1998

(2015) William L. Kelley et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

The Staphylococcus aureus Chaperone PrsA Is a New Auxiliary Factor of Oxacillin Resistance Affecting Penicillin-Binding Protein 2A

(2015) Ambre Jousselin et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

A multicentre study of meticillin-resistant Staphylococcus aureus in acute bacterial skin and skin-structure infections in China: Susceptibility to ceftaroline and molecular epidemiology

(2015) Hui Zhang et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Missense mutations of PBP2a are associated with reduced susceptibility to ceftaroline and ceftobiprole in African MRSA

(2015) Frieder Schaumburg et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Molecular characterization of MRSA isolates bracketing the current EUCAST ceftaroline-susceptible breakpoint forStaphylococcus aureus: the role of PBP2a in the activity of ceftaroline

(2015) Sushmita D. Lahiri et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Potential ofStaphylococcus aureusisolates carrying different PBP2a alleles to develop resistance to ceftaroline

(2015) Sushmita D. Lahiri et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

PBP2a substitutions linked to ceftaroline resistance in MRSA isolates from the UK: Table 1.

(2015) Ewan M. Harrison et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

In vitroactivity of ceftaroline against bacterial pathogens isolated from skin and soft tissue infections in Europe, Russia and Turkey in 2012: results from the Assessing Worldwide Antimicrobial Resistance Evaluation (AWARE) surveillance programme

(2015) James A. Karlowsky et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Comparative Genomics of Community-Associated Methicillin-ResistantStaphylococcus aureusShows the Emergence of Clone ST8-USA300 in Geneva, Switzerland

(2015) Elodie Von Dach et al.   JOURNAL OF INFECTIOUS DISEASES

The Tipper–Strominger Hypothesis and Triggering of Allostery in Penicillin-Binding Protein 2a of Methicillin-Resistant Staphylococcus aureus (MRSA)

(2015) Jennifer Fishovitz et al.   JOURNAL OF THE AMERICAN CHEMICAL SOCIETY

Ceftaroline fosamil versus ceftriaxone for the treatment of Asian patients with community-acquired pneumonia: a randomised, controlled, double-blind, phase 3, non-inferiority with nested superiority trial

(2015) Nan Shan Zhong et al.   LANCET INFECTIOUS DISEASES

Pre-Use Susceptibility to Ceftaroline in Clinical Staphylococcus aureus Isolates from Germany: Is There a Non-Susceptible Pool to be Selected?

(2015) Birgit Strommenger et al.   PLoS One

PBP2a Mutations Causing High-Level Ceftaroline Resistance in Clinical Methicillin-Resistant Staphylococcus aureus Isolates

(2014) S. Wesley Long et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Ceftaroline Is Active against Heteroresistant Methicillin-Resistant Staphylococcus aureus Clinical Strains despite Associated Mutational Mechanisms and Intermediate Levels of Resistance

(2014) Regina Fernandez et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Penicillin-binding protein 2a of methicillin-resistantStaphylococcus aureus

(2014) Jennifer Fishovitz et al.   IUBMB LIFE

Randomized non-inferiority trial to compare trimethoprim/sulfamethoxazole plus rifampicin versus linezolid for the treatment of MRSA infection

(2014) S. Harbarth et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Analysis of Staphylococcus aureus clinical isolates with reduced susceptibility to ceftaroline: an epidemiological and structural perspective

(2014) R. A. Alm et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Disruption of Allosteric Response as an Unprecedented Mechanism of Resistance to Antibiotics

(2014) Jennifer Fishovitz et al.   JOURNAL OF THE AMERICAN CHEMICAL SOCIETY

Antimicrobial activity of ceftaroline and comparator agents tested against bacterial isolates causing skin and soft tissue infections and community-acquired respiratory tract infections isolated from the Asia-Pacific region and South Africa (2010)

(2013) Helio S. Sader et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

How allosteric control of Staphylococcus aureus penicillin binding protein 2a enables methicillin resistance and physiological function

(2013) L. H. Otero et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

The Posttranslocational Chaperone Lipoprotein PrsA Is Involved in both Glycopeptide and Oxacillin Resistance in Staphylococcus aureus

(2012) Ambre Jousselin et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Characterization of methicillin-resistant Staphylococcus aureus displaying increased MICs of ceftaroline

(2012) R. E. Mendes et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Underestimation of Vancomycin and Teicoplanin MICs by Broth Microdilution Leads to Underdetection of Glycopeptide-Intermediate Isolates of Staphylococcus aureus

(2010) P. Vaudaux et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Increased Uptake and Improved Intracellular Survival of a Teicoplanin-Resistant Mutant of Methicillin-Resistant Staphylococcus aureus in Non-Professional Phagocytes

(2009) Adriana Renzoni et al.   CHEMOTHERAPY

Hospital-associated methicillin-resistant Staphylococcus aureus (HA-MRSA) in Italy

(2009) Floriana Campanile et al.   Annals of Clinical Microbiology and Antimicrobials

In Vitro Selection and Characterization of Ceftobiprole-Resistant Methicillin-Resistant Staphylococcus aureus

(2008) R. Banerjee et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY